Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 01, 16:00
Infinity Pharmaceuticals Free Cash Flow (Quarterly): -8.007M for June 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -8.007M |
| March 31, 2023 | -12.58M |
| December 31, 2022 | -8.90M |
| September 30, 2022 | -9.401M |
| June 30, 2022 | -10.60M |
| March 31, 2022 | -13.55M |
| December 31, 2021 | -9.718M |
| September 30, 2021 | -7.873M |
| June 30, 2021 | -9.568M |
| March 31, 2021 | -13.47M |
| December 31, 2020 | -8.509M |
| September 30, 2020 | -7.883M |
| June 30, 2020 | -7.595M |
| March 31, 2020 | -11.80M |
| December 31, 2019 | -9.642M |
| September 30, 2019 | -11.16M |
| June 30, 2019 | -7.352M |
| March 31, 2019 | -15.71M |
| December 31, 2018 | 16.36M |
| September 30, 2018 | -6.991M |
| June 30, 2018 | -4.826M |
| March 31, 2018 | -9.255M |
| December 31, 2017 | 1.191M |
| September 30, 2017 | -11.06M |
| June 30, 2017 | -9.707M |
| Date | Value |
|---|---|
| March 31, 2017 | -17.18M |
| December 31, 2016 | -20.97M |
| September 30, 2016 | -35.11M |
| June 30, 2016 | -46.80M |
| March 31, 2016 | -52.14M |
| December 31, 2015 | 81.76M |
| September 30, 2015 | -36.36M |
| June 30, 2015 | -34.70M |
| March 31, 2015 | -100.77M |
| December 31, 2014 | -47.98M |
| September 30, 2014 | 238.15M |
| June 30, 2014 | -30.08M |
| March 31, 2014 | -43.73M |
| December 31, 2013 | -36.88M |
| September 30, 2013 | -26.77M |
| June 30, 2013 | -26.43M |
| March 31, 2013 | -25.59M |
| December 31, 2012 | -36.72M |
| September 30, 2012 | -30.74M |
| June 30, 2012 | -2.526M |
| March 31, 2012 | -11.45M |
| December 31, 2011 | -9.274M |
| September 30, 2011 | -7.11M |
| June 30, 2011 | -8.797M |
| March 31, 2011 | -9.47M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-13.55M
Minimum
Mar 2022
-7.352M
Maximum
Jun 2019
-9.858M
Average
-9.568M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Athersys Inc | -3.847M |
| Merck & Co Inc | -743.00M |
| MEI Pharma Inc | -11.06M |
| Humanigen Inc | -7.059M |
| Bristol-Myers Squibb Co | 2.55B |